Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 11 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Nov 2025, Dec 2025, Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026, Aug 2026, Sep 2026 and Oct 2026.
- Largest single sale: $2.5M (4,846 shares) of United Therapeutics Corp on Jul 30, 2026. Filing
- Last sale before this period: Oct 15, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| United Therapeutics Corp (UTHR) | Chairperson & CEO, Director | Aug 18, 2003 | Oct 14, 2026 |
| BETA Technologies, Inc. (BETA) | Director | Feb 3, 2026 | Jun 12, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 13, 2026, United Therapeutics Corp: sold 9,500 shares for $5.2M, under a disclosed plan; 9,500 shares acquired by exercising options (some held indirectly). 1 filing: 1
- Oct 12, 2026, United Therapeutics Corp: sold 9,500 shares for $5.2M, under a disclosed plan; 9,500 shares acquired by exercising options (some held indirectly). 1 filing: 1
- Oct 9, 2026, United Therapeutics Corp: sold 9,500 shares for $5.2M, under a disclosed plan; 9,500 shares acquired by exercising options (some held indirectly). 1 filing: 1
- Oct 8, 2026, United Therapeutics Corp: sold 9,500 shares for $5.1M, under a disclosed plan; 9,500 shares acquired by exercising options (some held indirectly). 1 filing: 1
- Oct 7, 2026, United Therapeutics Corp: sold 9,500 shares for $5.2M, under a disclosed plan; 9,500 shares acquired by exercising options (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.